Selective laser trabeculoplasty, or SLT, is an FDA-approved laser procedure for the treatment of open-angle glaucoma. SLT is an advanced treatment option that lowers eye pressure and increases fluid drainage. It is minimally-invasive and uses low levels of energy to selectively pinpoint the areas of the trabecular meshwork, relieving the symptoms of glaucoma. If needed, the procedure can be repeated several times without causing damage to surrounding tissue.
Advantages of SLT for Glaucoma
Performed as an in-office procedure, SLT takes just a few minutes yet provides long-term results. Other advantages of the SLT procedure include:
- Selective targeting of areas within the trabecular meshwork
- Minimal damage to surrounding tissue
- Reduction of intraocular pressure (IOP) by about 30 percent
- Minimal side effects
- Procedure can be repeated
SLT controls glaucoma symptoms for up to 5 years with no need for additional medication, and relieves symptoms by promoting the body's natural healing response. There are no major risks or complications associated with SLT and the procedure is covered by most major insurance companies.